Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SKYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 157.28M
March 31, 2026 178.78M
December 31, 2025 264.38M
September 30, 2025 433.21M
June 30, 2025 14.54M
March 31, 2025 10.14M
December 31, 2024 1.996M
September 30, 2024 6.506M
June 30, 2024 7.217M
March 31, 2024 6.861M
December 31, 2023 7.934M
September 30, 2023 10.60M
Date Value
June 30, 2023 8.689M
March 31, 2023 10.97M
December 31, 2022 9.641M
September 30, 2022 9.720M
June 30, 2022 12.00M
March 31, 2022 1.627M
December 31, 2021 3.169M
September 30, 2021 3.435M
June 30, 2021 2.860M
March 31, 2021
December 31, 2020 2.131M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Daxor Corp. --
Strive, Inc. (United States) 1.349B
Solana Co. 169.69M
Abbott Laboratories 51.11B
Acme United Corp. 121.30M

Shareholders Equity (Quarterly) Related Metrics